Trial Profile
Phase III, Multicentre, Non-comparative, Open and Single Stage Study to Assess the Efficacy and Safety of Pamoate of Triptorelin 11.25 MG in Children With Precocious Puberty
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Apr 2022
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Precocious puberty
- Focus Registrational; Therapeutic Use
- Acronyms DECAPUB
- Sponsors Ipsen
- 28 Apr 2017 New trial record